Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04451824
Other study ID # CL100 CR RetrX1
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2018
Est. completion date December 31, 2018

Study information

Verified date June 2020
Source Contour Research
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The rationale for the selection of Outcome Measures is the compliance with FDA regulations as pertain to medical devices with a moderate level of risk of hazard leading to harm of the patient; firstly, the safety of the device in achieving the desired effect of its intended use when operated in the intended manner; and secondly, the effectiveness of the device in achieving its desired effect of its intended use in accordance with its proposed label and labeling. The rationale for the selection of the primary outcome measure is to satisfy the question of safety and effectiveness of the use of red-light exposure to reduce the circumference of overweight patients with a statistically significant Routine Use population size. Given that the Routine Use Data Analysis is open label and therefore not blinded, there is no need for a control group nor additional cohorts for varying levels of exposure and corresponding safety and/or effectiveness.


Description:

In the 1960s, the concept of using light energy for a variety of health maintenance goals and overcoming a number of dermatological conditions began in earnest to receive the attention of NASA researchers as a means of providing desired clinical outcomes to astronauts while in the confines of a space capsule over long periods of time. The research was well funded and supported by the U.S. government, and confirmed the value of light emitting diode (LED) low-level light therapy (LLLT), in particular red light from the 635nm frequency, for producing a variety of healthful effects within the dermis. The ability to achieve a reduction in the dimensions of exposed liposomes using red light is intended to be confirmed by analyzing the clinical data from a minimum of one hundred patients who were exposed to the 635 nm frequency for 30 minutes by use of the subject device (Contour Light) during routine use to confirm that the device is safe and effective for its intended application. Please see the following clinical articles, appended in section 10.


Recruitment information / eligibility

Status Completed
Enrollment 118
Est. completion date December 31, 2018
Est. primary completion date November 30, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Males and Females ages 18 and above

- Generally good health

Exclusion Criteria:

- Pregnancy

- Active cancer within the past year

- Pacemaker

- Diminished ability to void waste (liver and/or kidney function impairment)

- Photosensitivity (generally and/or from medication)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
CL-100
Red Light LED device for circumferential reduction

Locations

Country Name City State
United States Love Clinic Kirkland Washington
United States Barone Clinic Savannah Georgia
United States Gibson Clinic Vista California

Sponsors (1)

Lead Sponsor Collaborator
Contour Research

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Examination of Circumferential Reduction - Primary Objective To confirm the proper use of the device induces a change in the circumference of the patients thighs, hips and waist, when exposed to the red light (635nm) <1 hour
Secondary Examination of Circumferential Reduction - Secondary Objective To achieve a contour change, specifically a lessening of the protrusion of body fat, when exposed to the red light (635nm) <1 hour
See also
  Status Clinical Trial Phase
Recruiting NCT06013163 - A Phase 1 Study to Evaluate EMP22 PD and EMP16 PK Versus Xenical® in Healthy Volunteers Phase 1
Active, not recruiting NCT03843424 - Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & Providers N/A
Not yet recruiting NCT06360536 - Remotely Delivered Resistance Training for Cardiometabolic Health Among Black Women N/A
Not yet recruiting NCT05997576 - A Study of TG103 Injection in Non-diabetic Overweight or Obesity Phase 3
Recruiting NCT04763291 - Cardiovascular and InflammAging Study N/A
Active, not recruiting NCT04399460 - The Effects of Long-term Consumption of Full-fat Dairy Products on Satiety, Body Weight and Glycemic Control N/A
Completed NCT04110717 - Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control as a Means of Reducing Excess Body Weight N/A
Completed NCT05561855 - T2DM Intensity Lifestyle Intervention N/A
Active, not recruiting NCT04100200 - Berries, Inflammation, and Gut Microbiome N/A
Recruiting NCT06125964 - eMOTION Formative Study N/A
Recruiting NCT06087822 - Multicenter Trial Investigating Performance and Safety of the Medical Device SiPore21® N/A
Active, not recruiting NCT04328233 - Impact of Time-Restricted Eating on Metabolic Homeostasis, Inflammation and Oxidative Stress in Metabolic Syndrome N/A
Completed NCT06091761 - Thread Embedding Acupuncture Combined With Auricular Acupuncture for Overweight and Obesity N/A
Completed NCT04894344 - Education to Decrease in Sodium Intake Evaluated With 24 Hour Urinary Sodium Excretion (RCT) N/A
Completed NCT05713461 - Physical Exercise in Obesity for Health and Quality of Life. N/A
Not yet recruiting NCT06054698 - Efficacy and Safety of HRS9531 Injections in Overweight or Obese Subjects Phase 2
Not yet recruiting NCT02823912 - Capsaicin Effect on Cytokines Profile in Dyslipidemia Phase 2/Phase 3
Completed NCT05104151 - Efficacy of a Nutritive Bar, in Reduction of Weight, Body Fat and Control of Appetite N/A
Completed NCT04786925 - Precision Nutrition Strategies for Improving the Quality of Life of Pre-senior and Senior Populations N/A
Enrolling by invitation NCT06092632 - Efficacy of Pigmented Rice on Reducing Cardiometabolic Risk Factors Among Filipino Adults N/A